Pradaxa – Oral Direct Thrombin Inhibitor
Key Data:
Drug (brand/generic)
Pradaxa (dabigatran etexilate)
Company/Licensee
Boehringer Ingelheim
Therapy Class
Anticoagulant
Product Description
Direct thrombin inhibitor
Current Indication
Primary prevention and treatment of VTE following orthopaedic surgery
Market Sector
Cardiovascular
Development Status
Approved Europe
